AMLX
Price
$3.87
Change
-$0.03 (-0.77%)
Updated
Apr 15, 04:59 PM (EDT)
Capitalization
345.55M
23 days until earnings call
ATYR
Price
$2.98
Change
-$0.03 (-1.00%)
Updated
Apr 15, 04:59 PM (EDT)
Capitalization
267.46M
22 days until earnings call
Ad is loading...

AMLX vs ATYR

Header iconAMLX vs ATYR Comparison
Open Charts AMLX vs ATYRBanner chart's image
Amylyx Pharmaceuticals
Price$3.87
Change-$0.03 (-0.77%)
Volume$1.47K
Capitalization345.55M
aTyr Pharma
Price$2.98
Change-$0.03 (-1.00%)
Volume$7.78K
Capitalization267.46M
AMLX vs ATYR Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. ATYR commentary
Apr 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and ATYR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 15, 2025
Stock price -- (AMLX: $3.90 vs. ATYR: $3.01)
Brand notoriety: AMLX and ATYR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 192% vs. ATYR: 44%
Market capitalization -- AMLX: $345.55M vs. ATYR: $267.46M
AMLX [@Biotechnology] is valued at $345.55M. ATYR’s [@Biotechnology] market capitalization is $267.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $281.29B to $0. The average market capitalization across the [@Biotechnology] industry is $1.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileATYR’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • ATYR’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than ATYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while ATYR’s TA Score has 2 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 4 bearish.
  • ATYR’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than ATYR.

Price Growth

AMLX (@Biotechnology) experienced а +12.72% price change this week, while ATYR (@Biotechnology) price change was +5.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.87%. For the same industry, the average monthly price growth was -13.42%, and the average quarterly price growth was -21.44%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 07, 2025.

ATYR is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+8.87% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($346M) has a higher market cap than ATYR($267M). AMLX YTD gains are higher at: 3.175 vs. ATYR (-16.851). ATYR has higher annual earnings (EBITDA): -66.37M vs. AMLX (-290.98M). AMLX has more cash in the bank: 177M vs. ATYR (72.1M). AMLX has less debt than ATYR: AMLX (1.98M) vs ATYR (13.3M). AMLX has higher revenues than ATYR: AMLX (87.4M) vs ATYR (235K).
AMLXATYRAMLX / ATYR
Capitalization346M267M130%
EBITDA-290.98M-66.37M438%
Gain YTD3.175-16.851-19%
P/E Ratio2.81N/A-
Revenue87.4M235K37,191%
Total Cash177M72.1M245%
Total Debt1.98M13.3M15%
FUNDAMENTALS RATINGS
ATYR: Fundamental Ratings
ATYR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
31

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXATYR
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
58%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
72%
Momentum
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
85%
MACD
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
84%
Advances
ODDS (%)
Bullish Trend 27 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
82%
Bearish Trend 12 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
71%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL202.524.37
+2.21%
Apple
GME26.980.58
+2.20%
GameStop Corp
BTC.X84542.390000857.406250
+1.02%
Bitcoin cryptocurrency
SPY539.125.18
+0.97%
SPDR® S&P 500® ETF
TSLA252.350.04
+0.02%
Tesla

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with ATRA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then ATRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+6.85%
ATRA - AMLX
65%
Loosely correlated
+5.79%
GRI - AMLX
57%
Loosely correlated
+13.53%
SLRX - AMLX
54%
Loosely correlated
+8.59%
RGNX - AMLX
44%
Loosely correlated
+7.47%
SCPX - AMLX
43%
Loosely correlated
-2.72%
More

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with MGTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
+1.35%
MGTX - ATYR
44%
Loosely correlated
+5.38%
NTLA - ATYR
37%
Loosely correlated
+1.21%
CRNX - ATYR
35%
Loosely correlated
+2.30%
VERV - ATYR
35%
Loosely correlated
+26.38%
ERAS - ATYR
34%
Loosely correlated
N/A
More